Keyphrases
Pulmonary Arterial Hypertension
100%
Pulmonary Hypertension
54%
Hereditary Hemorrhagic Telangiectasia
36%
Lung Transplantation
34%
Bronchiolitis Obliterans Syndrome
17%
Acute Rejection
15%
Treprostinil
10%
Delphi Consensus
9%
6-minute Walk Distance (6MWD)
9%
Confidence Interval
9%
Epistaxis
8%
Medical Therapy
8%
Idiopathic Pulmonary Arterial Hypertension
8%
Vascular Malformation
7%
Oral Treprostinil
7%
Portopulmonary Hypertension
7%
Genotype-phenotype Correlation
7%
Phosphodiesterase Type 5 Inhibitors
7%
Patient Characteristics
7%
Brain Vascular Malformation
7%
Clinical Trials
6%
Hypertension Patients
6%
Pulmonary Arteriovenous Malformation
6%
Health-related Quality of Life
6%
Pulmonary Vascular Resistance
6%
Respiratory Viral Infection
6%
Hospitalization
5%
Cyclic GMP
5%
Patient Management
5%
Delivery System
5%
Pulmonary Circulation
5%
Consensus Recommendations
5%
Community-acquired
5%
Allograft Dysfunction
5%
Clinical Outcomes
5%
Medicine and Dentistry
Pulmonary Hypertension
98%
Lung Transplantation
25%
Hereditary Hemorrhagic Telangiectasia
24%
Treprostinil
13%
Acute Graft Rejection
12%
Bronchiolitis Obliterans
10%
Combination Therapy
10%
Diseases
8%
Quality of Life
8%
Portopulmonary Hypertension
7%
Hemodynamic
7%
Vascular Anomaly
6%
Pulmonary Arteriovenous Fistula
6%
Cerebrovascular Malformation
6%
Placebo
5%
Health Care
5%
Prostacyclin
5%
Lung
5%
Pulmonary Circulation
5%
Phosphodiesterase V Inhibitor
5%
Atrial Septal Defect
5%
